13.6.2015   

EN

Official Journal of the European Union

C 197/1

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32015M7617. EUR-Lex is the online access to European law.

13.6.2015   

EN

Official Journal of the European Union

C 197/2

13.6.2015   

EN

Official Journal of the European Union

C 197/3

1.

On 5 June 2015, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Castleton Commodities International LLC (‘Castleton’, USA) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of parts of Morgan Stanley (USA), namely the Morgan Stanley Global Oil Merchanting Unit by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7665 — Castleton/Morgan Stanley Global Oil Merchanting Unit, to the following address:

13.6.2015   

EN

Official Journal of the European Union

C 197/4

1.

On 3 June 2015 the European Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Aberdeen Infrastructure (HoldCo) BV (‘Aberdeen’, Netherlands) and Iridium Concesiones de Infraestructuras, SA (‘Iridium’, Spain) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Concessionaria Hospital Universitari Son Espases, SA (‘HSE’, Spain) by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   Aberdeen: belongs to the Aberdeen group, which manages the assets of both institutions and retail clients around the world;

—   Iridium: is controlled by ACS Servicios y Concesiones SL, which is engaged in all manner of activities related to administrative concessions;

—   HSE: is jointly controlled by Iridium Concesiones de Infraestructuras, SA (‘Iridium’) and Globalvía Infraestructuras, SA (‘IVG’) and operates the concession of the non-health services of Son Espases hospital in Palma de Mallorca.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit to it their observations on the proposed concentration.

Observations must reach the Commission no later than 10 days following the date on which this notification is published. They can be sent to the Commission under reference number M.7575 — Iridium/Aberdeen/Concessionaria Hospital Universitari Son Espases by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, to the following address: